1Lun
It's a good thing if you also separate in the event that it no longer fits your own strategy.
Why "basic consumption / industry / health"? Simply so that you can make sensible suggestions. There is already a certain range of companies...
Why "basic consumption / industry / health"? Simply so that you can make sensible suggestions. There is already a certain range of companies...
•
11
•
1Lun
@KevinE because two healthcare stocks have now been kicked out and these have always been underrepresented in my portfolio. Currently (albeit with cash) these sectors are only around 2-4%, with tech accounting for around 18% (cash-adjusted around 36%). Industrials even have a 1 in front of the decimal point.
••
1Lun
@lawinvest At Basiskonsum I have Hershey and Cranswick on the WL. However, both would still have to come down a bit for an entry.
I am still waiting for a dip in Watsco, Badger Meter and Xylem.
I find healthcare very difficult to evaluate. It is underrepresented in my portfolio. In my opinion, Stryker is very well positioned for the future, but the valuation has completely slipped away from me. A friend of mine swears by Abbvie, but I'm not sure what will happen after Humira's patent expires as the best-selling drug. Since I'm not very good at assessing these step-by-step procedures for new drug approvals, I've so far kept my hands (or money) completely off drug manufacturers...
I am still waiting for a dip in Watsco, Badger Meter and Xylem.
I find healthcare very difficult to evaluate. It is underrepresented in my portfolio. In my opinion, Stryker is very well positioned for the future, but the valuation has completely slipped away from me. A friend of mine swears by Abbvie, but I'm not sure what will happen after Humira's patent expires as the best-selling drug. Since I'm not very good at assessing these step-by-step procedures for new drug approvals, I've so far kept my hands (or money) completely off drug manufacturers...
•
11
•